Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Chaput

Showing results (171-180 of 194) with videos related to

Pageof 20
Sort By:
Alcoholism, Clinical and Experimental Research|February 1, 1995
Prevalence of cholelithiasis according to alcoholic liver disease: a possible role of apolipoproteins AI and AIIT Poynard, I Lonjon, P Mathurin, et al.
Gastroenterologie Clinique Et Biologique|August 3, 1999
[Descriptive epidemiology of patients with alcoholic liver disease hospitalized in a hepato-gastroenterology service]S Naveau, E Borotto, V Giraud, et al.
Gut|January 5, 2002
Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control studyM Bardou, S Montembault, V Giraud, et al.
European Cytokine Network|July 21, 2000
Pretreatment expression of the perforin gene by circulating CD8(+) T lymphocytes predicts biochemical response to interferon-alpha in patients with chronic hepatitis CA Balian, S Naveau, W Zou, et al.
Journal of Hepatology|August 1, 1988
Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trialD Lebrec, T Poynard, J P Capron, et al.
Hepatology (Baltimore, Md.)|May 1, 1991
Independent risk factors for hepatocellular carcinoma in French drinkersT Poynard, A Aubert, Y Lazizi, et al.
Gastroenterology|February 13, 2001
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tractA Veyradier, A Balian, M Wolf, et al.
La Nouvelle Presse Medicale|April 11, 1981
[Follow-up of alcoholic patients in a hepatogastroenterology unit. Preliminary results (author's transl)]D Labayle, J P Dejonghe, L Papoz, et al.
Presse Medicale (Paris, France : 1983)|October 19, 2002
[Regenerative nodular hyperplasia: variable clinical aspects]G Tomatis, A Balian, I de Pinieux, et al.
Journal of Hepatology|August 1, 1997
Interleukin-1 receptor antagonist plasma concentration is specifically increased by alpha-2A-interferon treatmentS Naveau, D Emilie, E Borotto, et al.
Pageof 20

Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Alcoholism, Clinical and Experimental Research|February 1, 1995
Prevalence of cholelithiasis according to alcoholic liver disease: a possible role of apolipoproteins AI and AIIT Poynard, I Lonjon, P Mathurin, et al.
Gastroenterologie Clinique Et Biologique|August 3, 1999
[Descriptive epidemiology of patients with alcoholic liver disease hospitalized in a hepato-gastroenterology service]S Naveau, E Borotto, V Giraud, et al.
Gut|January 5, 2002
Excessive alcohol consumption favours high risk polyp or colorectal cancer occurrence among patients with adenomas: a case control studyM Bardou, S Montembault, V Giraud, et al.
European Cytokine Network|July 21, 2000
Pretreatment expression of the perforin gene by circulating CD8(+) T lymphocytes predicts biochemical response to interferon-alpha in patients with chronic hepatitis CA Balian, S Naveau, W Zou, et al.
Journal of Hepatology|August 1, 1988
Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trialD Lebrec, T Poynard, J P Capron, et al.
Hepatology (Baltimore, Md.)|May 1, 1991
Independent risk factors for hepatocellular carcinoma in French drinkersT Poynard, A Aubert, Y Lazizi, et al.
Gastroenterology|February 13, 2001
Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tractA Veyradier, A Balian, M Wolf, et al.
La Nouvelle Presse Medicale|April 11, 1981
[Follow-up of alcoholic patients in a hepatogastroenterology unit. Preliminary results (author's transl)]D Labayle, J P Dejonghe, L Papoz, et al.
Presse Medicale (Paris, France : 1983)|October 19, 2002
[Regenerative nodular hyperplasia: variable clinical aspects]G Tomatis, A Balian, I de Pinieux, et al.
Journal of Hepatology|August 1, 1997
Interleukin-1 receptor antagonist plasma concentration is specifically increased by alpha-2A-interferon treatmentS Naveau, D Emilie, E Borotto, et al.
Pageof 20